Skip to content

A research study to see the effect of shatavari ghrita in assessing the membrane intactness of spermatozoa using Hypoosmotic swelling test

A clinical study on the role of Shatavari ghrita in hypoosmotic swelling(HOS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019036
Enrollment
50
Registered
2019-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Shatavari ghrita: In the form of ghrita, administered at the dose of 15ml twice daily for a period of 1month before food, orally Control Intervention1: none: none

Sponsors

KLEU Ayurveda Pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: the individuals having HOS value less than 70%

Exclusion criteria

Exclusion criteria: Individuals having major seminal abnormalities like severe oligospermia, with severe metaboic disorders affecting the semen quality, chronic smokers and alcoholic

Design outcomes

Primary

MeasureTime frame
after administering the drug it was assumed to be 60% efficaciousTimepoint: the assessment will be done Before the treatment, after 4 weeks and after 10 weeks of treatment

Secondary

MeasureTime frame
expected that the shatavari ghrita will be beneficial in improving the intactness of the sperm membraneTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Shivakumar Harti

KLEUBMK Ayurveda Mahavidyalaya, Belgaum

dr_bsprasad@rediffmail.com9448569289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026